Sesterterpenoids with anticancer activity

Current Medicinal Chemistry

Volumn 22, Issue 30, 2015, Pages 3502-3522

  Evidente, Antonio ^a   Kornienko, Alexander ^b   Lefranc, Florence ^c   Cimmino, Alessio ^a   Dasari, Ramesh ^b   Evidente, Marco ^a   Mathieu, Véronique ^d   Kiss, Robert ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Texas State University   (United States)

^c ERASME HOSPITAL   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Apoptosis resistance; Glioma; In vivo; Manoalide; Multidrug resistance; Ophiobolin A; Scalarane

Indexed keywords

ANTINEOPLASTIC AGENT; APLYSINOPLIDE A; CACOSPONGIONOLIDE; CARBOTRICYCLIC OPHIOBOLANE DERIVATIVE; DIACARNOXIDE; FURANOSESTERTERPENE TETRONIC ACID; FUROSPINOSULIN 1; HIPPOLIDE A; HYDROQUINONE DERIVATIVE; IRCIFORMONIN I; KOHAMAIC ACID; LINTENOLIDE; LUFFARIELLOLIDE; MANOALIDE; OPHIOBOLIN A; OPHIOBOLIN O; OPHIOBOLIN U; PALAUOLOL; PETROSASPONGIOLIDE; POLYCYCLIC ANTHRACENONE DERIVATIVE; POLYCYCLIC FURAN 2 ONE DERIVATIVE; POLYCYCLIC HYDROCARBON; SCALARANE DERIVATIVE; SECOEMESTRIN D; SESTERSTATIN 4; SESTERSTATIN 5; SESTERTERPENE; SESTERTERPENOID DERIVATIVE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; BIOLOGICAL PRODUCT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIUM; BIOLOGICAL ACTIVITY; CANCER CELL LINE; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; FUNGUS; HUMAN; MARINE SPECIES; NONHUMAN; PLANT; STRUCTURE ACTIVITY RELATION; AQUATIC SPECIES; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS;

ANTINEOPLASTIC AGENTS; AQUATIC ORGANISMS; BIOLOGICAL PRODUCTS; CELL SURVIVAL; FUNGI; HUMANS; PLANTS; SESTERTERPENES;

EID: 84946606281     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867322666150821101047     Document Type: Article

References (98)

1. Dewick, P.M. Medicinal Natural Products-A Biosynthetic Approach. John Wiley & Sons Ltd: Chichester, 2009; pp. 197-306.
2. Osbourn, A.E.; Lanzotti, V. Plant-derived Natural Products-Synthesis, Function and Application, Springer: Dortdrecht, 2009, pp. 3-50.
3. Cimmino, A.; Andolfi, A.; Evidente, A. Phytotoxic terpenes produced by phytopathogenic fungi and allelopathic plants. Nat. Prod. Comm., 2014, 9, 401-408.
4. Schnitzler, J.-P.; Louis, S.; Behnke, K.; Loivamäki, M. Poplar volatiles-biosynthesis, regulation (eco)physiology of isoprene and stress-induced isoprenoids. Plant Biol. 2012, 12, 302-316.
5. Banthorpe, D.V.; Charlwood, B.V.; Francis, M.J.O. The Biosynthesis of monoterpenes. Chem. Rev., 1972, 72, 115-119.
6. Mohamoud, S.S.; Croteau, R.B. Strategies for transgenic manipulation of monoterpene biosynthesis in plants. Trends Plant Sci., 2002, 7, 366-373.
7. Cordell, G.A. Biosynthesis of sesquiterpenes. Chem. Rev., 1976, 76, 425-460.
8. Barnes C.S.; Loder, J.W. Structure of Polygodial-A new sesquiterpene dialdehyde from Polygonum hydropiper L. Aust. J. Chem., 1962, 15, 322-327.
9. Vanderah, D.J.; Rutledge, N.; Schmitz, F.J.; Ciereszko, L.S. Marine natural products: cembrene-A and cembrene-C from a soft coral, Nephthea species. J. Org. Chem., 1978, 43, 1614-1616.
10. Lam, L.K; Sparnins, V.L; Wattenberg, L.W. Isolation and identification of kahweol palmitate and cafestol palmitate as active constituents of green coffee beans that enhance glutathione S-transferase activity in the mouse. Cancer Res., 1982, 42, 1193-1198.
11. González, M.A. Scalarane sesterterpenoids. Curr. Bioact. Comp., 2010, 6, 178-210.
12. Au, T.K.; Chick, P.C.; Leung, P.C. The biology of ophiobolins. Life Sci., 2000, 67, 733-742.
13. Rudi, A.; Yesief, T.; Schleyer, M.; Kashman, Y. Bilosespens A and B: two novel cytotoxic sesterpenes from the marine sponge Dysidea cinerea. Org. Lett., 1999, 1, 471-472.
14. Wang, L.; Yang, B.; Lin, X.-P.; Zhou, X.-F.; Liu, Y. Sesterterpenoids. Nat Prod. Rep., 2013 30, 455-473.
15. Sakoulas, G.; Nam, S-J.; Loesgen, S.; Fenuical, W.; Gensen, P.R.; Nizet, V.; Hensler, M. Novel bacterial metabolite merhochlorin A demonstrates in vitro activities against multi-drug resistant methicillin-resistant Staphylococcus aureus. PLoS One, 2012, 7, e29439.
16. Ballio, A.; Graniti, A. Phytotoxins and their involvment in plant disease. Experientia, 1981, 47, 751-864.
17. Sassa, T. Cotylenines, leaf growth substances produced by fungus. Part I. Isolation and characterization of cotylenins. Agric. Biol. Chem., 1971, 35, 1415-1418.
18. Sassa, T.; Neguro, T.; Ueki, H. Production and characterization of a new fungal metabolite, cotylenol. Agric. Biol. Chem., 1972, 36, 2281-2285.
19. Canonica, L.; Fiecchi, A.; Galli Kienle, M.; Scala, A. The constitution of cochliobolin. Tetrahedron Lett., 1966, 11, 1211-1218.
20. Nozoe, S.; Hirai, K.; Tsuda, K. The structure of zizanin-A and-B, C25-terpenoids isolated from Helminthosporium zizaniae. Tetraedron Lett., 1966, 20, 2211-2216.
21. Canonica, L.; Fiecchi, A.; Galli Kienle, M.; Scala, A. Isolation and constitution of cochliobolin. Tetrahedron Lett., 1966, 13, 1329-1333.
22. Itai, A.; Nozoe, S.; Tsuda, K.; Okuda, S.; Iitaka, Y.; Makayama, Y. Structure of cephalonic acid, a pentaprenyl terpenoid. Tetraedron Lett.,1967, 42, 4111-4112.
23. Nozoe, S.; Itai, A.; Tsuda, K.; Okuda, S. Chemical trasformation of cephalonic acid. Tetraedron Lett.,1967, 42, 4113-4117.
24. Nozoe, S.; Morisaki, M.; Fukushima, K.; Okuda, S. The isolation of an acyclic C25-isoprenoid alcohol, geranylnerolidol, and a new ophiobolin. Tetraedron Lett.,1968, 42, 4457-4458.
25. Evidente, A.; Andolfi, A.; Cimmino, A.; Vurro, M.; Fracchiolla, M.; Charudattan, R. Herbicidal potential of ophiobolins produced by Drechslera gigante. J. Agic. Food Chem., 2006, 54, 1779-1783.
26. Evidente, A.; Andolfi, A.; Cimmino, A.; Vurro, M.; Fracchiolla, M.; Charudattan, R.; Motta, A. Ophiobolin E and 8-epi-ophiobolin J produced by Drechslera gigantea, a potential mycoherbicide of weedy grasses. Phytochemistry, 2006, 67, 2281-2287.
27. Tipton, C. L.; , Paulsen, P.V.; Betts, R. E. Effects of ophiobolin A on ion leakage and hexose uptake by maize roots. Plant Physiol., 1977, 59, 907-910.
28. Cocucci, S. H.; Morgutti, S.; Cocucci, M.; Ginani, L. Effects of ophiobolin A on potassium permeability, transmembrane electrical potential and proton extrusion in maize root. Plant Sci., 1983, 32, 9-16.
29. Bury, M.; Novo-Uzal, E.; Andolfi, A.; Cimini, S.; Wauthoz, N.; Heffeter, P.; Lallemand, B.; Avolio, F.; Delporte, C.; Cimmino, A.; Dubois, J.; Van Antwerpen, P.; Zonno, M.C.; Vurro, M.; Poumay, Y.; Berger, W.; Evidente, A.; De Gara, L.; Kiss, R.; Locato, V. Ophiobolin A, a sesterterpenoid fungal phytotoxin, displays higher in vitro growthinhibitory effects in mammalian than in plant cells and displays in vivo antitumor activity. Int. J. Oncol., 2013, 38, 227-232.
30. Fujiwara, H.; Matsunaga, K.; Kumagai, H.; Ishizuka, M.; Ohizumi, Y. Ophiobolin A, a novel apoptosis-inducing agent from fungus strain f-7438. Pharm. Pharmacol. Commun., 2000, 6, 427-431.
31. Bury, M.; Girault, A.; Megalizzil, V.; Spiegl-Kreinecker, S.; Mathieu, V.; Berger, W.; Evidente, A.; Kornienko, A.; Gailly P.; Vandier, C.; Kiss, R. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. Cell Death Dis., 2013, 4, e561.
32. Morrison, R.; Gardiner, C.; Evidente, A.; Kiss, R.; Townley, H. Incorporation of ophiobolin A into novel chemoembolization particles for cancer cell treatment. Pharm. Res., 2014, 31, 290-2917.
33. Lefranc, F.; Brotchi, J.; Kiss, R. Possible future issues in the treatment of glioblastomas, with a special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol., 2005, 23, 2411-2422.
34. Lefranc, F.; Sadeghi, N.; Camby, I.; Metens, T.; Dewitte, O.; Kiss, R. Present and potential future issues in glioblastoma treatment. Expert Rev. Anticancer Ther., 2006, 6, 719-732
35. Yang, T.; Lu, Z.; Meng, L.; Wei, S.; Hong, K.; Zhu, W.; Huang, C. The novel agent ophiobolin O induces apoptosis and cell cycle arrest of MCF-7 cells through activation of MAPK signalling pathways. Bioorg. Med. Chem. Lett., 2012, 22, 579-585.
36. Sun, W.; Lv, C.; Zhu, T., Yang, X.; Wei, S.; Sun, J.; Hong, K.; Zhu, W.; Huang, C. Ophiobolin-O reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human breast carcinoma (MCF-7/ADR) cells. Mar. Drugs, 2013, 11, 4570-4584.
37. Wang, Q.-X.; Bao, L.; Yang, X.-L.; Liu, D.-L.; Guo, H.; Dai, H.-Q.; Song, F.-H.; Zhang, L.-X.; Guo L.-D.; Li, S.-J.; Liu, H.W. Ophiobolins P-T, five new cytotoxic and antibacterial sesterterpenes from the endolichenic fungus Ulocladium sp. Fitoterapia, 2013, 90, 220-227.
38. Elizabeth, A.A. Understanding the diversity of foliar endophytic fungi progress, challenges, and frontiers. Fungal Biol. Rev., 2007, 21, 51-66.
39. Thorskov Bladt, T.; Dürr, C.; Boldsen Knudsen, P.B.; Kildgaard, S.; Frisvad, J.C.; Held Gotfredsen, C.; Seiffert, M.; Ostenfeld Larsen, T. Bio-Activity and dereplication-based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells. Molecules, 2013, 18, 14629-14650.
40. Wei, H.; Itoh, T.; Kinoshita, M.; Nakai, Y.; Kurotaki, M.; Kobayashi, M. Cytotoxic sesterterpenes, 6-epi-ophiobolin G and 6-epi-ophiobolin N, from marine derived fungus Emericella variecolor GF10. Tetrahedron, 2004, 60, 6015-6019.
41. Xu, Y.-M.; Espinosa-Artiles, P.; Liu, M.X.; Arnold, A.E.; Gunatilaka, A.A.L. Secoemestrin D, a cytotoxic epitetrathiodioxopiperizine, and emericellenes A?E, five sesterterpenoids from Emericella sp. AST0036, a fungal endophyte of Astragalus lentiginosus. J. Nat. Prod., 2013, 76, 2330-2336.
42. Hawksworth, D. L. Naming Aspergillus species: progress towards one name for each species. Med. Mycol., 2011, 49, S70-S76.
43. Rank, C.; Nielsena, K.F.; Larsena, T.O.; Vargab, J.; Samsonc, R. A.; Frisvad, J.C. Distribution of sterigmatocystin in filamentous fungi. Fungal Biol., 2011, 115, 406-420.
44. Vijeratne, F.M.K.; Bashyal, B.P.; Liu, M.X.; Rocha, D.D.; Gunaherath, G.M.K.B.; U'Ren, J.M. Gunatilaka, M.K. Arnold, A.E.; Whitsell, L.; Gunatilaka, A.A.L. Geopyxins A-E, ent-kaurane diterpenoids from endolichenic fungal strains Geopyxis aff. majalis and Geopyxis sp. AZ0066: structure-Activity relationships of geopyxins and their analogues. J. Nat. Prod., 2012, 75, 361-369.
45. Potts, B.C.M.; Faulker, D.J; Jacobs, R.S. Phospholipase A2 inhibitors from marine organisms. J. Nat. Prod., 1992, 55, 1701-1717.
46. Glaser K.B.; de Carvalho M.S.; Jacobs R.S.; Kernan M.R.; Faulkner D.J. Manoalide: structure-Activity studies and definition of the pharmacophore for phospholipase A2 inactivation. Mol. Pharmacol., 1989, 36, 782-788.
47. Ebada, S.S.; Lin, W.H; Proksch, P. Bioactive sesterterpenes and triterpenes from marine sponge: occurrence and pharmacological significance. Mar. Drugs, 2010, 8, 313-346.
48. Gross, H.; König, G.M.; Terpenoids from marine organisms: unique structures and their pharmacological potential. Phytochem. Rev., 2006, 5, 115-141.
49. Elkhayat, E.; Edrada, R.A.; Ebel, R.; Wray, V.; van Soest, R.; Wiryowidagdo, S.; Mohamed, M.H.; Muller, W.E.G.; Proksch, P. New luffariellolide derivatives from the Indonesian sponge Acanthodendrilla sp. J. Nat Prod., 2004, 67, 1809-1817.
50. Tsuda, M.; Shigemori, H.; Ishibashi, M.; Sasaki, T. Luffariolides A-E, new cytotoxic sesterpenes from the Okinawan marine sponge Luffariella sp. J. Org. Chem., 1992, 57, 3503-3507.
51. Kobayashi, J.; Zeng, C.M.; Ishibashi, M.; Sasaki, T. Luffariolides F and G, new manoalide derivatives from the Okinawan marine sponge Luffariella sp. J. Nat. Prod., 1993, 56, 436-439.
52. Piao, S.-J.; Zhang, H.-J.; Lu, H.-I.; Yang, F.; Jiao, W.-H.; Yi, Y.-H.; Chen, W-S, Lin H-W. Hippolides A-H, acyclic manoalide derivatives from the marine sponge Hippospongia lachne. J. Nat. Prod., 2011, 74, 1248-1254.
53. Mathieu, A.; Remmelink, M.; D'Haene, N.; Penant, S.; Gaussin, J.F.; Van Ginckel, R.; Darro, F.; Kiss, R.; Salmon, I. Development of a chemoresistant orthotopic human nonsmall cell lung carcinoma model in nude mice: Analyses of tumor heterogeneity in relation to the immunohistochemical levels of expression of cyclooxygenase-2, ornithine decarboxylase, lung-related resistance protein, prostaglandin E synthetase, and glutathione-S-transferase-Alpha (GST)-Alpha-, GST-mu, and GST-pi. Cancer, 2004, 101, 1908-1918.
54. Ueoka, R.; Nakao, Y.; Fujii, S; van Soest, W.M.; Matsunaga, S. Aplysinoplides A-C, cytotoxic sesterterpenes from the marine sponge Aplysinopsis digitata. J. Nat. Prod., 2008, 71, 1089-1091.
55. Pettit, G.R.; Tan, R.; Melody, N.; Cichacz, Z.A.; Herald, D.L.; Hoard, M.S.; Pettit, R.K.; Chapuis, J.C. Antineoplastic agents 397: isolation and structure of sesterstatins 4 and 5 from Hyrtios erecta (The Republic of Maldive). Bioorg. Med. Chem. Lett., 1998, 8, 2093-2098.
56. Shen, Y.-C.; Lo, K.-L.; Lin, Y.-C.; Khalil, A.T.; Kuo, Y.-K.; Shih, P.-S. Novel linear C22-sesterterpenoids from sponge Ircinia formosana. Tetrahedron Lett., 2006, 47, 4007-4010.
57. Su, J.-H.; Tseng, S.-W.; Lu, M.-C.; Liu, L.-L.; Chou, Y.; Sung, P.-J. Cytotoxic C21 and C22 terpenoid-derived metabolites from the sponge Ircinia sp. J. Nat. Prod., 2011, 74, 2005-2009.
58. Liu, Y.; Bae, B.H.; Alam, N.; Ong, J.; Sim, C.J.; Lee, C.O.; Im, K.S.; Jung, J.H. New cytotoxic sesterterpenes from the sponge Sarcotragus species. J. Nat. Prod., 2001, 64, 1301-1304.
59. Arai, M.; Kawachi, T.; Seitawan, A.; Kobayashi, M. Hypoxia-selective growth inhibition of cancer cells by furospinosulin-1, a furanosesterpene isolated from an Indonesian marine sponge. Chem. Med. Chem., 2010, 5, 1919-1926.
60. Kotoku, N.; Fujioka, S.; Nakata, C.; Yamada, M.; Sumii, Y.; Kawachi, T.; Arai, M.; Kobayashi, M. Concise synthesis and structure-Activity relationship of furospinosulin-1 a hypoxia-selective growth inhibitor from marine sponge. Tetrahedron, 2011, 67, 6673-6678.
61. Dai, J.; Liu, Y.; Zhou, Y.-D.; Nagle, D.G. Hypoxiaselective antitumor agents: norsesteterpene peroxides from the marine sponge Diacarnus levii preferentially suppress the growth of tumor cells under hypoxia conditions. J. Nat. Prod., 2007, 70, 648-651.
62. Charan, R.D.; McKee, T.C.; Boyd, M.R. Thorectandrols C, D and E, new sesterterpenes from the marine sponge Thorectandra sp. J. Nat. Prod., 2002, 65, 492-495.
63. De Rosa, S.; De Stefano, S.; Zavodnik N. Cacospongionolide: a new antitumoral sesterpene, from the marine sponge Cacospongia mollior. J. Org. Chem., 1988, 53, 5020-5023.
64. De Rosa, S.; De Giulio, A.; Crispino, A.; Iodice, C.; Tommonaro, G. Further bioactive sesterterpenes from the Tyrrhenian sponge Fasciospongia cavernosa. Nat. Prod. Res., 1997, 10, 267-274.
65. De Stefano, D.; Tommonaro, G.; Malik, S.A.; Iodice, C.; De Rosa, S.; Maiuri, M.C.; Carnuccio, R.; Cacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines. Plos One, 2007, 4, e33031.
66. Bae, J.; Jeon, J.E.; Lee, Y.J.; Lee, S.H.; Sim, C.J.; Oh, K.B.; Shin, J. Sesterterpenes from the tropical sponge Coscinoderma sp. J. Nat. Prod., 2011, 74, 1805-1811.
67. Lefranc, F.; Kiss, R. The sodium pump alpha-1 subunit as a potential target to combat apoptosis-resistant glioblastomas. Neoplasia, 2008, 10, 198-206.
68. Mathieu, V.; Pirker, C.; Martin de Lassalle, E.; Vernier, M.; Mijatovic, T.; DeNeve, N.; Gaussin, J.F.; Dehoux, M.; Lefranc, F.; Berger, W.; Kiss, R. The sodium pump alpha-1 subunit: a disease progression-related target for metastatic melanoma treatment. J. Cell. Mol. Med., 2009, 13, 3960-3972.
69. Mijatovic, T.; Jungwirth, U.; Heffeter, P.; Reza Hoda, M.A.; Dornetshuber, R.; Kiss, R.; Berger, W. The Na+/K+-ATPase is the Achilles Heel of multidrug resistant cancer cells. Cancer Lett., 2009, 282, 30-34.
70. Kokubo, S.; Yogi, K.; Uddin, M.J.; Inuzuka, T.; Suenaga, K.; Ueda, K.; Uemura, D. Kohamaic acids A and B, novel cytotoxic sesterterpenic acids, from the marine sponge Ircinia sp. Chem. Lett., 2001, 2, 176-177.
71. Mizushina, Y.; Manita, D.; Takeuchi, T.; Sugawara, F.; Kumamoto-Yonezawa, Y.; Matsui, Y.; Takemura, M.; Sasaki, M.; Yoshida, H.; Takikawa H. The inhibitory action of kohamaic acid A derivatives on mammalian DNA polymerase ?. Molecules, 2009, 14, 102-121.
72. Gomez-Paloma, L.; Randazzo, A.; Minale, L.; Debitus, C.; Roussakis, C. New cytotoxic sesterterpenes from the new Caledonian marine sponge Petrosaspongia nigra (Bergquist). Tetrahedron, 1997, 53, 10451-10458.
73. Monti, M.C.; Casapullo, A.; Cavasotto, C.N.; Tosco, A.; Dal Piaz, F.; Ziemys, A.; Margarucci, L.; Riccio, R. The binding mode of petrosaspongiolide M to the human group IIA phospholipase A(2): exploring the role of covalent and noncovalent interactions in the inhibition process. Chem. Eur. J., 2009, 15, 1155-1163.
74. Margarucci, L.; Monti, M.C.; Tosco, A.; Riccio, R.; Casapullo, A. Chemical proteomics discloses petrosapongiolide M, an antiinflammatory marine sesterterpene, as a proteasome inhibitor. Angew. Chem.-Int. Ed., 2010, 49, 3960-3963.
75. Pal, A.; Young, M.A.; Donato, N.J. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer. Cancer Res., 2014, 74, 4955-4966.
76. Johnson, D.E. The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors. Endocr. Relat. Cancer, 2015, 22, T1-17.
77. Bowden, B.F.; Coll, J.C.; Li, H.; Cambie, R.C.; Chernan, M.R.; Bergquist, P.R. New cytotoxic scalarane sesterterpenes from the Dictyoceratida sponge Strepsichorabia lendenfeldi. J. Nat. Prod., 1992, 55, 1234-1240.
78. Ryu, G.; Matsunaga, S.; Fusetani, N. Three new cytotoxic sesterterpenes from the marine sponge Hyrtios cf. erectus. J. Nat. Prod., 1996, 59, 515-517.
79. Carotenuto, A.; Fattorusso, E.; Lanzotti, V.; Magno, S.; Carnuccio, R.; Iuvone, T. Antiproliferative sesterterpenes from the caribbean sponge Cacospongia cf. linteiformis Comp. Biochem. Physiol., 1998, 119C, 119-123.
80. Somerville, M.J.; Hooper, J.N.A.; Garson, M.J. Mooloolabenes A-E, norsesterterpenes from the Australian sponge Hyattella intestinalis. J. Nat. Prod., 2006, 69, 1587-1590.
81. Diaz-Marrero, A.R.; Matainaho, T.; van Soest, R.; Roberge, M.; Andersen, R.J. Scalarane-based metabolites isolated from the antimitotic extract of the marine sponge Hyrtios erectus. Nat. Prod. Res., 2008, 22, 1304-1309.
82. Jeon, J.E.; Bae, J.; Lii, K.J.; Oh, K.B.; Shen, J. Scalarane sesterterpenes from the sponge Hyatella sp. J. Nat. Prod., 2011, 74, 847-851.
83. Zhang, H.-J.; Fang, H.-F.; Yi, Y.-H.; Lin, H.-W. Scalarane sesterpenes from the Chinese spongia Phyllospongia foliascens. Helv. Chim. Acta, 2009, 92, 762-767.
84. Chang, Y.-C.; Tseng, S.-W.; Liu, L.-L.; Chou, Y.; Ho, Y.-S.; Lu, M.-C.; Su, J.-H. Cytotoxic sesterterpenoids from a sponge Hyppospongia sp. Mar. Drugs, 2012, 10, 987-997.
85. Schumacher, M.; Cerella, C.; Eifes, S.; Chateuvieux, S.; Morceau, F.; Jaspars, M.; Dicato, M.; Diederich M. Heteronemin, a spongean sesterterpene, inhibits TNF alphainduced NF-kB activation through proteasome inhibition and induces apoptotic cell death. Biochem. Pharmacol., 2010, 79, 610-622.
86. Rudi, A.; Yosief, T.; Schleyer, M.; Kashman, Y. Bilosespens A and B: Two novel cytotoxic sesterpenes from the marine sponge Dysidea cinerea. Org. Lett., 1999, 1, 471-472.
87. Hussain, S.; Slevin, M.; Matou, S.; Ahmed, N.; Iqbal Choudhary, M.; Ranjit, R.; West, D.; Gaffney, J. Anti-Angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesis. Angiogenesis, 2008, 11, 245-256.
88. Dal Piaz, F.; Vassallo, A.; Lepore, L.; Tosco, A.; Bader, A.; De Tommasi, N. Sesterterpenes as tubulin tyrosine ligase inhibitors. First insight of structure-Activity relationships and discovery of new lead. J. Med. Chem., 2009, 52, 3814-3828.
89. Kornienko, A.; Mathieu, V.; Rastogi, S.K.; Lefranc, F.; Kiss, R. Therapeutic agents triggering nonapoptotic cancer cell death. J. Med. Chem., 2013, 56, 4823-4839.
90. Darro, F.; Decaestecker, C.; Gaussin, J.F.; Mortier, S.; Van Ginckel, R.; Kiss, R. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? Int. J. Oncol., 2005, 27, 607-616.
91. Soengas, M.S.; Lowe, S.W. Apoptosis and melanoma chemoresistance. Oncogene, 2003, 22, 3138-3151.
92. Mathieu V., Mijatovic T., Van Damme M., Kiss R. Gastrin exerts pleitropic effects on human melanoma cell biology. Neoplasia, 2005, 7, 930-943.
93. Chiarugi, P.; Giannoni, E. Anoikis: A necessary death program for anchorage-dependent cells. Biochem. Pharmacol., 2008, 76, 1352-1364.
94. Simpson, C. D.; Anyiwe, K.; Schimmer, A. D. Anoikis resistance and tumor metastasis. Cancer Lett., 2008, 272, 177-185.
95. Wong, H. H. and Lemoine, N. R. Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat. Rev. Gastroenterol. Hepatol., 2009, 6, 412-422.
96. Bussink, J.; van Herpen, C.; Kaanders, J.; Oyen, W. PETCT for response assessment and treatment adaptation in head and neck cancer. Lancet Oncol., 2010, 11, 661-669.
97. Kennedy, B.; Gargoum, F.; Bystricky, B.R.; Curran, D.M.; O'Connor, T. Novel agents in the management of lung cancer. Curr. Med. Chem., 2010, 17, 4291-4325.
98. Xu, Y.; Espinosa-Artiles, P.; Liu, M. X.; Arnold, A. E.; Gunatilaka, A. A. L. Secoemestrin D, a Cytotoxic Epitetrathiodioxopiperizine, and Emericellenes AE, Five Sesterterpenoids from Emericella sp. AST0036, a Fungal Endophyte of Astragalus lentiginosus. J. Nat. Prod., 2013, 76, 2330-2336.